Amy Couch, MD
Family Medicine · Washington, MONPI 1275730152
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,962 of the $41,886 with a category attached, or 64.4%. Reprise Biomedical, Inc. accounts for 69.0% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $25,772 and has fallen 92.2% since, to $2,020 in 2025. Among family medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $118.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reprise Biomedical, Inc.$29K
- Imbed Biosciences Inc.$4K
- ETS Wound Care LLC$2K
- Smith+Nephew$1K
- Organogenesis Inc.$1K
- Integra Lifesciences Corporation$772
- plus $3K from 19 others
What the payments were for
- Consulting fees$26,96264%
- Travel & lodging$8422%
- Food & beverage$14,08234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reprise Biomedical, Inc. | 29 | $28,913 |
| Imbed Biosciences Inc. | 68 | $4,447 |
| ETS Wound Care LLC | 46 | $1,941 |
| Smith+Nephew | 50 | $1,272 |
| Organogenesis Inc. | 64 | $1,264 |
| Integra Lifesciences Corporation | 26 | $772 |
| Nuo Therapeutics | 11 | $612 |
| Koya Medical, Inc. | 4 | $604 |
| Kerecis Limited | 6 | $344 |
| Next Science LLC | 9 | $304 |
| Convatec Inc. | 6 | $301 |
| Hydrofera LLC | 12 | $292 |
| Tactile Systems Technology Inc | 3 | $174 |
| AbbVie | 6 | $129 |
| Hartmann USA, Inc. | 2 | $121 |
| Avita Medical Americas, LLC | 2 | $74 |
| Cook Medical LLC | 1 | $61 |
| Solventum Corporation | 2 | $54 |
| Elite Orthopedics, LLC | 1 | $53 |
| Progenacare Global, LLC | 1 | $42 |
| Prytime Medical Devices, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| KCI USA, Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $20 |
| Acera Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MIRO3D$28,004
- MIRRAGEN ADVANCED WOUND MATRIX$1,031
- MIRO3D FIBERS$1,011
- Miroderm$898
- Dayspring$743
- INTEGRA$494
- Kerecis SurgiClose$473
- Koya Medical$382
- Kerecis Omega3 Marigen$349
- GRAFIX PL$338
- Dayspring Controller$323
- LEG GARMENT, DAYSPRING, STANDARD$323
- Arm Garmet, Dayspring, Medium$323
- LOWER LEG GARMENT, DAYSPRING$323
- PuraPly$246
- STRAVIX PL$226
- Miro 3D$180
- INTEGRA DERMAL REGENERATION TEMPLATE$165
- PRIMATRIX$165
- MiroMiroTract$132
How this compares
$41,886 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 17 | $14,185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $167 |
| Ciprofloxacin Hcl | 12 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,272 | $14,18517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Washington
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.